Emmaus Life Sciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $21.4M
Liabilities Breakdown FY2025
Total Liabilities: $85.0M
Asset Breakdown
Total Assets: $21.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.1M | 9.9% |
| Accounts Receivable | $2.8M | 13.1% |
| Inventory | $1.6M | 7.3% |
| Property, Plant & Equipment | $113.0K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $14.8M | 69.2% |
Liabilities Breakdown
Total Liabilities: $85.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.0M | 7.0% |
| Long-Term Debt | $27.1M | 31.9% |
| Other Liabilities | $51.9M | 61.1% |